Actively Recruiting
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
Led by M.D. Anderson Cancer Center · Updated on 2025-12-24
45
Participants Needed
1
Research Sites
123 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.
CONDITIONS
Official Title
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed and dated electronic informed consent form provided
- Willingness to comply with all study procedures and available for the study duration
- Age 18 years or older
- Documented diagnosis of chemotherapy-induced peripheral neuropathy with symptom onset matching timing of neurotoxic chemotherapy and reports of peripheral neuropathy symptoms
- Access to smartphone and internet for technology-based intervention
- Upcoming in-person appointment at Main Hospital Pain Management Clinic within 4 to 6 weeks of consent
- English-speaking
- Pain or bothersome symptoms present most days with an average of 4 or higher on the Numeric Rating Scale for at least 3 months
- Not currently receiving cancer treatment or on stable maintenance treatment for at least 3 months
- Resides in the Houston Metroplex area
- Score of 7 or less on Six Item Cognitive Impairment Test (6CIT) indicating unimpaired cognition
You will not qualify if you...
- Signed and dated electronic informed consent form provided
- Willingness to comply with all study procedures and available for the study duration
- Age 18 years or older
- Documented diagnosis of chemotherapy-induced peripheral neuropathy with symptom onset matching timing of neurotoxic chemotherapy and reports of peripheral neuropathy symptoms
- Access to smartphone and internet for technology-based intervention
- Upcoming in-person appointment at Main Hospital Pain Management Clinic within 4 to 6 weeks of consent
- English-speaking
- Pain or bothersome symptoms present most days with an average of 4 or higher on the Numeric Rating Scale for at least 3 months
- Not currently receiving cancer treatment or on stable maintenance treatment for at least 3 months
- Resides in the Houston Metroplex area
- Score of 7 or less on Six Item Cognitive Impairment Test (6CIT) indicating unimpaired cognition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
A
Alice Ye, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here